Research programme: engineered HIV vaccines - The Scripps Research Institute/International AIDS Vaccine Initiative/La Jolla Institute for Allergy and Immunology

Drug Profile

Research programme: engineered HIV vaccines - The Scripps Research Institute/International AIDS Vaccine Initiative/La Jolla Institute for Allergy and Immunology

Alternative Names: eOD GT8 60mer

Latest Information Update: 12 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator International AIDS Vaccine Initiative; La Jolla Institute for Allergy & Immunology; The Scripps Research Institute
  • Developer International AIDS Vaccine Initiative; La Jolla Institute for Allergy & Immunology; Rockefeller University; The Scripps Research Institute
  • Class AIDS vaccines; Protein-vaccines
  • Mechanism of Action B cell stimulants; Immunogenetic stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical HIV infections

Most Recent Events

  • 24 Mar 2016 The Scripps Research Institute, International AIDS Vaccine Initiative and La Jolla Institute for Allergy and Immunology are planning a phase I trial for HIV infections in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top